Serum tumor markers expression (CA199, CA242, and CEA) and its clinical implications in type 2 diabetes mellitus

Table 1 General characteristics was compared between two groups

Variables	Control group (n = 51)	T2DM group (n = 82)	χ2/Z/t value	P value
Gender (male/female)	27/24	47/35	0.244	0.621
Age (yr)	57.98 ± 11.72	59.02 ± 11.58	0.503	0.616
ALT (U/L)	18.40 (13.20, 28.30)	18.75 (13.48, 30.93)	0.558	0.577
AST (U/L)	18.80 (11.80, 30.10)	16.25 (12.48, 24.80)	0.694	0.488
SUA (mmol/L)	312.51 ± 119.36	306.20 ± 102.97	0.323	0.747
Cre (mmol/L)	68.36 ± 27.54	70.16 ± 28.67	0.357	0.721
HbA1c (%)	5.30 (4.30, 6.60)	9.30 (8.18, 11.13)	9.013	0
FBG (mmol/L)	4.46 ± 0.89	10.08 ± 4.30	9.199	0
BMI (kg/m2)	25.15 ± 4.28BMI	25.55 ± 3.40	0.602	0.548
LDL-C (mmol/L)	2.30 (1.90, 3.30)	2.34 (1.94, 3.23)	0.201	0.84
TG (mmol/L)	1.40 (1.10, 2.30)	1.81 (1.09, 2.68)	1.581	0.144
TC (mmol/L)	4.45 ± 1.39	4.46 ± 1.29	0.049	0.961

T2DM: Type 2 diabetes mellitus; ALT: Alanine transaminase; AST: Aspartate transaminase; SUA: Serum uric acid; Cre: Creatinine; HbA1c: Glycosylated hemoglobin; FBG: Fasting blood sugar; BMI: Body mass index; LDL-C: Low-density lipoprotein cholesterol; TG: Triglycerides; TC: Total cholesterol.